Sign in and upgrade to a paid plan to export dividends as CSV.
Sign in and upgrade to a paid plan to export announcements as CSV.
Sign in and upgrade to a paid plan to export announcements as CSV.
Sign in and upgrade to a paid plan to export dividends as CSV.
Sign in and upgrade to a paid plan to export corporate actions as CSV.
Sign in and upgrade to a paid plan to export bulk/block deals as CSV.
Sign in and upgrade to a paid plan to export dividends as CSV.
Sign in and upgrade to a paid plan to export dividends as CSV.
Sign in and upgrade to a paid plan to export dividends as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.

3B Blackbio Dx Limited

Healthcare · Healthcare Services

NSE: 3BBLACKBIO BSE: 532067
₹1710.40
▲ 87.70 (5.40%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
69/100
Moderate
Valuation
19/100
Expensive
Momentum
86/100
Bullish

QVM read Momentum-led Quality Moderate, Valuation Expensive, Momentum Bullish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹1,468 Cr
PE (TTM)
28.8
Industry median 50.2 (44 companies)
Price to Book
4.4
PEG (TTM)
8.5
Institutions holding %
4.65%
FII + DII, latest filed period
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
44.8
Relative return vs Sector, qtr %
45.2
Free Cash Flow
₹27 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
13.27%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
-1.65%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
6.94%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
13.26%
as of June 30, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
12.71%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
5.27
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.01
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
1912.94
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
61.50%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
79.99%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
69.15%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
12.45%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
20.38%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
13.67%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

4 of 6 met
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.01)
  • No Return on equity is 15% or more (13.7%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 2 met
  • No Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

2 of 4 met
  • No Valuation score is Undervalued (70 or more)
  • Yes Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
5.4%
Low 1610.5000 · High 1740.0000
1W return
19.5%
Low 1381.0000 · High 1740.0000
1M return
18.1%
Low 1283.2000 · High 1740.0000
52W return
Data unavailable.
Low 1085.0000 · High 1740.0000
Lifetime High ₹1710.4000 (Sept. 30, 2026)
Lifetime Low ₹1102.8000 (June 1, 2026)

Full price history and technicals →

EMA & SMA

Bullish5
Bearish0
5D
1584.5
10D
1512.6
20D
1451.8
50D
1368.4
100D
1301.8

Delivery and volume

Day avg. delivery
36.9%
Week avg. delivery
38.8%
Month avg. delivery
46.7%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

1686.97
Pivot
First resistance1763.43
Second resistance1816.47
Third resistance1892.93
First support1633.93
Second support1557.47
Third support1504.43
Day RSI72.6
Day MFI75.8
Day MACD67.98
Day MACD signal41.78

Beta

1M0.32
3M0.04
1Y0.69
3Y0.69

Price change analysis

↑ 18.1%
Over 1 Month
LowHigh
1283.201740.00
↑ 42.4%
Over 3 Months
LowHigh
1099.501740.00
—
Over 6 Months
LowHigh
1085.001740.00
—
Over 1 Year
LowHigh
1085.001740.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹23 Cr
Net profit (June 30, 2026)
₹14 Cr
Basic EPS (June 30, 2026)
₹16.4700

Ranks #31 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter40.95%
  • FII/FPI2.50%
  • Other DII2.15%
  • Public54.40%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings increased from 40.94% to 40.95% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 2.57% to 2.50% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 0.00% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
26 Feb 2021 NIRANJAN S SHETY Bulk Sell 105,000 287.4400 BSE
14 Sep 2020 YUGA DOSHI Bulk Buy 45,000 319.1700 BSE
10 Aug 2020 LENUS FINVEST PRIVATE LIMITED Bulk Buy 40,000 492.8900 BSE
10 Aug 2020 ALPHA LEON ENTERPRISES LLP Bulk Buy 41,020 481.4100 BSE
10 Aug 2020 ALPHA LEON ENTERPRISES LLP Bulk Sell 56,496 491.6400 BSE
29 Jul 2020 OWN INFRACON PRIVATE LIMITED Bulk Sell 100,000 360.0000 BSE
29 Jul 2020 VARUN DAGA Bulk Sell 100,000 360.0000 BSE
29 Jul 2020 SEVEN CANYONS WORLD INNOVATORS FUND Bulk Buy 170,000 360.0000 BSE
16 Jul 2020 ALPHA LEON ENTERPRISES LLP Bulk Buy 38,469 276.4100 BSE
16 Jul 2020 ALPHA LEON ENTERPRISES LLP Bulk Sell 61,497 276.8500 BSE

All bulk and block deals →

Last 12 months ₹5.00 per share
Dividend yield 0.29%
Ex-dateSubjectPer share (₹)Record date
22 Sep 2026 Dividend - Rs 5 Per Share 5.0000 22 Sep 2026

Corporate Actions

Full history (2 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Kilpest India Ltd. to 3B BlackBio Dx Limited

All corporate actions →

Corporate Announcements

All 11 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 AGM/EGM 3B BlackBio Dx Ltd - 532067 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
30 Sep 2026 Company Update 3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Change in Management
29 Sep 2026 AGM/EGM 3B BlackBio Dx Ltd - 532067 - Shareholder Meeting / Postal Ballot-Outcome of AGM
25 Sep 2026 Insider Trading / SAST 3B BlackBio Dx Ltd - 532067 - Closure of Trading Window
18 Sep 2026 Company Update 3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Newspaper Publication
16 Sep 2026 Company Update 3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
11 Sep 2026 Company Update 3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
11 Sep 2026 Company Update 3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
8 Sep 2026 Company Update 3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Newspaper Publication
5 Sep 2026 Company Update 3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong net profit margin (61.5%)
  • Low financial leverage (Debt/Equity 0.01)
  • Comfortable interest coverage (1912.9x)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • RSI in overbought territory (72.6)

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about 3B Blackbio Dx Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.